(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MEDISTUS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MEDISTUS

ST13

US500000079206566

Class

5

Filing

79206566

Registration

5393501

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

27

Latest update

07/23/2026

Trademark type

Word

Nice classes

5

Filing date

07/29/2016

Registration date

02/06/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/23/2024

Last transaction

07/23/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

98

Owner location

HU

Examiner

HESIK, APRIL ANNE

Law office

N60

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

C. K. (pessoa física)
Vitaplus Élelmiszer, Gyógyszergyártó és Kereskedelmi Korlátolt Felelosségu Társaság

Representatives

Engel és Eszes Ügyvédi Iroda

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Aldehydes for pharmaceutical purposes; Alginate dietary supplements; Aloe vera preparations for pharmaceutical purposes; Amino acids for medical purposes; Anti-oxidant food supplements; Antioxidantsfood supplements; Antibiotics; Antibiotics for human use; Mineral food supplements; Antioxidant pillsfood supplements; Mineral water salts for medical purposes; Mineral waters for medical purposes; Asthmatic tea; Bacteriological preparations for medical and veterinary use; Cultures of microorganisms for medical use; Cultures of microorganisms for veterinary use; Bacterial poisons; Bacterial preparations for medical and veterinary use; Medicinal ointments for the treatment of viral and bacterial infections; Balms for medical purposes; Balsamic preparations for medical purposesnamely balms for medical purposes; Biological tissue cultures for veterinary purposes; Biological preparations for medical purposes for the treatment of viral and bacterial infections; Biological preparations for veterinary purposes for the treatment of viral and bacterial infections; Biological tissue cultures for medical purposes; medicated skin care lotions; Skin care creams for medical use; Wheat germ dietary supplements; Melissa water for pharmaceutical purposes; Gallic acid for pharmaceutical purposes; Stick liquorice for pharmaceutical purposes; Fennel for medical purposes; Dietary fiber for constipation; Yeast for pharmaceutical purposes; Yeast dietary supplements; Yeast extracts for pharmaceutical purposes; Elixirs being pharmaceutical preparations for the treatment of viral and bacterial infections; Enzymes for medical purposes; Enzyme preparations for medical purposes; Tonics being medicines for the treatment of viral and bacterial infections; Enzyme dietary supplements; Eucalyptol for pharmaceutical purposes; Eucalyptus for pharmaceutical purposes; Sterilising preparations; Disinfectants other than disinfectant soap; Disinfectants and antiseptics; Germicides; disinfectantsother than disinfectant soap; Disinfectants for medical instruments; Fumigants; Glucose for medical purposes; By-products of the processing of cereals for medical purposes; Glucose dietary supplements; Glucose preparations for medical purposes; Fungicides; Fungicidal fungal agents; Medicinal tea; Medicinal herbs; Medicated candy; Extracts of medicinal herbs; Herbal teas for medicinal purposes; Herbal beverages for medicinal use; Medicinal herbal extracts for medical purposes; Drugs for medical purposesfor the treatment of respiratory infections; Medicated lozenges; medicated dragees being medicated candy; Medicated food supplements; Herbal medicine; Extracts of medicinal plants; Pharmaceuticals and natural remedies for the treatment of respiratory infections; pharmaceutical compositions for the treatment of respiratory infections; pharmaceutical sweets; pharmaceuticals for the treatment of respiratory infections; smoking herbs for medical purposes; medicated food supplements for human consumptionfood additives for medicinal purposes namelygum arabictisanes being medicated herbal beverages; urinary tract disinfectants; Anti-uric preparations; vaginal washes for medical purposes; douching preparations for medical purposes; Irish moss for medical purposes; Iodine; Iodine for pharmaceutical purposes of disinfection; Iodides for pharmaceutical purposes of disinfection; Camphor oil for medical purposes; Camphor for medical purposes; Candy for medical purposes; Dill oil for medical purposes; Capsules sold empty for medicines; Parasiticides; Tissues impregnated with pharmaceutical lotions; Disinfectants impregnated into tissues; pre-moistened wipes for medical use; Ointments for pharmaceutical purposes for the treatment of viral and bacterial infections; Sulfur sticks being disinfectants; Flowers of sulfur for pharmaceutical purposes; Angostura bark for medical purposes; Mangrove bark for pharmaceutical purposes; Quebracho bark for medical use; Condurango bark for medical purposes; Croton bark for medical purposes; Collodion for pharmaceutical purposes; Extracts of hops for pharmaceutical purposes; Lupulin for pharmaceutical purposes; Air purifying preparations; disinfectant washesother than soapfor hygenic purposes; Sterilizing washes for hygenic purposes; Royal jelly for pharmaceutical purposes; Royal jelly dietary supplements; Mint for pharmaceutical purposes; Menthol for pharmaceutical purposes; Preparations of microorganisms for medical or veterinary usecultures of microorganism; Mustard for pharmaceutical purposesmustard plasters; Mustard powder for medical purposes; Mustard oil for medical purposes; Mustard preparations for medical purposesmustard plasters; Medicinal roots; Pine barks for pharmaceutical purposes; Dietary supplementspreparations of trace elements for human and animal use; Dietary supplementstrace element preparations for human use; Cachets for pharmaceutical purposesgelatin capsules sold empty; Medicinal oils; Lozenges for pharmaceutical purposes; Cough pastilles for medical use; Pollen dietary supplements; Propolis for pharmaceutical purposes; Propolis dietary supplements; Chewing gum for medical purposes; Salts for medical purposessodium salts for medical purposes; Medicated mouthwash; Mouthwashes for medical purposes; Mouthwashes being gargles for medical purposes; Medicated mouth spray; medicated dental rinse; medicated antiseptic mouthwashes; Medicated antimicrobial mouthwashes; medicated serums for the treatment of mouth and throat; Syrups for pharmaceutical purposes for mouth disinfection and the treatment of respiratory diseases; Tinctures for medical purposes for mouth disinfection and the treatment of respiratory diseases; Detergents for medical purposes; Vaccines; Vitamin tablets; Vitamin preparations; Vitamin supplements; Effervescent vitamin tablets; Mixed vitamin preparations; Gelatine for medical purposesempty capsules and gelatine gum pastilles; Fumigation preparations for medical purposes; gurjungurjon or gurjan balsam for medical purposes; Bronchodilating preparations

Publications

History of USPTO decisions and trademark events.

27 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

07/23/2026

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

08/22/2025

INTS

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

08/03/2025

INPC

INVALIDATION PROCESSED

08/03/2025

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

04/23/2025

CHLD

CHANGE OF OWNER RECEIVED FROM IB

02/08/2025

C71T

CANCELLED SECTION 71

08/23/2024

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

07/20/2018

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

05/16/2018

XXCR

GENERIC MADRID TRANSACTION CREATED

05/16/2018

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

05/06/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

02/06/2018

PUBO

PUBLISHED FOR OPPOSITION

11/21/2017

NPUB

NOTICE OF PUBLICATION

11/01/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/13/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/05/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/05/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/05/2017

RFNP

REFUSAL PROCESSED BY IB

06/09/2017

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

05/23/2017

RFRR

REFUSAL PROCESSED BY MPU

05/23/2017

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

05/14/2017

CNRT

NON-FINAL ACTION WRITTEN

05/13/2017

MAFR

APPLICATION FILING RECEIPT MAILED

05/09/2017

DOCK

ASSIGNED TO EXAMINER

05/05/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/05/2017

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

05/04/2017

Continuous trademark protection

Get notified about every new filing that threatens MEDISTUS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.